期刊
BIOMOLECULES
卷 12, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/biom12020172
关键词
macrophage; monocyte; inflammation; epigenetics; cardiometabolic; vascular
资金
- National Institutes of Health [F32-DK117545, 1R01HL156274-01A1]
- American College of Surgeons Resident Fellowship
- Vascular and Endovascular Surgery Society Resident Research Award
Abdominal aortic aneurysm (AAA) is a life-threatening disease with a lack of pharmaceutical treatment options. Previous studies have shown that epigenetic modifications play a crucial regulatory role in the development of AAA. This review discusses the roles and significance of epigenetic modifications in AAA animal models and their relevance to human pathology.
Abdominal aortic aneurysm (AAA) is a life-threatening disease associated with high morbidity and mortality in the setting of acute rupture. Recently, advances in surgical and endovascular repair of AAA have been achieved; however, pharmaceutical therapies to prevent AAA expansion and rupture remain lacking. This highlights an ongoing need to improve the understanding the pathological mechanisms that initiate formation, maintain growth, and promote rupture of AAA. Over the past decade, epigenetic modifications, such as DNA methylation, posttranslational histone modifications, and non-coding RNA, have emerged as important regulators of cellular function. Accumulating studies reveal the importance of epigenetic enzymes in the dynamic regulation of key signaling pathways that alter cellular phenotypes and have emerged as major intracellular players in a wide range of biological processes. In this review, we discuss the roles and implications of epigenetic modifications in AAA animal models and their relevance to human AAA pathology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据